Market News & Trends
Owlstone Medical Raises $15 Million to Drive Commercialization of Breath Biopsy Platform
Owlstone Medical Ltd recently announced that it has raised $15 million to drive the global commercialization of its Breath Biopsy platform. The funds will enable…
CDMO Pfizer CentreOne Launches Green-Chemistry Progesterone API
CDMO Pfizer CentreOne Launches Green-Chemistry Progesterone API Pfizer CentreOne recently announced the introduction of Enviero progesterone into the API marketplace. Enviero progesterone is produced by…
Majority of Clinical Trials Planned in 2018 Belong to Oncology
Cancer is one of the leading causes of morbidity and mortality across the world. Not surprisingly, oncology is going to be the top therapy area…
Evotec & Sanofi to Create an Evotec-Led Infectious Disease Open Innovation R&D Platform
Evotec AG and Sanofi have entered into exclusive negotiations for Evotec to accelerate infectious disease research and development through a new open innovation platform near…
Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement With the University of Massachusetts Medical School
Fortress Biotech recently announced that its subsidiary, Aevitas Therapeutics, Inc. (Aevitas), has entered into a sponsored research agreement (SRA) with the laboratory of Guangping Gao,…
PCI Completes Acquisition of Australia-Based Pharmaceutical Packaging Professionals
Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) recently announced the completion of its acquisition of Melbourne, Australia-based Pharmaceutical Packaging Professionals (PPP). PPP is…
Idera Pharmaceuticals Announces Launch of Global Phase 3 Trial
Idera Pharmaceuticals, Inc. recently announced the start of a Phase 3 global, multi-center, open-label clinical trial to evaluate the efficacy and safety of intratumoral IMO-2125…
Galera Therapeutics Receives FDA Breakthrough Therapy Designation
Galera Therapeutics, Inc. recently announced that the US FDA has granted Breakthrough Therapy designation to lead candidate GC4419, a highly selective and potent small molecule…
Elligo Health Research & Saama Technologies Announce Strategic Partnership
Elligo Health Research is partnering withSaama Technologies, Inc. to improve awareness of, access to, and participation in clinical trials for US physicians and patients. “We…
CicloMed Announces First Patient Dosed With Ciclopirox Prodrug in Phase I Trial
CicloMed LLC recently announced that the first patient has been dosed in a Phase I clinical trial. The CPX-POM-001 study is characterizing the safety, dose…
BC Platforms Launches End-to-End Solution for Precision Medicine Powered by the Microsoft Genomics Service
BC Platforms, a pioneer in genomic data management and analytics, recently announced it has launched GeneVision, a new end-to-end Solution for Precision Medicine, that uses…
Vividion Therapeutics Announces Strategic Research Collaboration With Celgene; $101 Million Up-Front Payment
Vividion Therapeutics, Inc., a biotechnology company using revolutionary proteomics and chemistry platforms, recently announced a strategic research collaboration with Celgene Corporation. The multi-year collaboration is focused…
Aduro Announces Development Milestone Achieved Under Merck Collaboration
Aduro Biotech, Inc. recently announced that the company earned a $3-million development milestone payment under its worldwide licensing agreement with Merck (known as MSD outside…
ProJect Pharmaceutics Expands Facilities for Formulation & Lyophilization Process Development
ProJect Pharmaceutics (PJP), specialized in formulation and process development for parenteral drug products, announces that it has extended its safety facilities by laboratories dedicated to…
Fierce Competition Amongst Checkpoint Inhibitor Developers Ahead
Over the next ten years, PD-(L)1 inhibitors will continue to dominate the checkpoint modulators market, says leading data and analytics company GlobalData. PD-(L)1 inhibitors are…
Catalent Completes Multi-Million Expansion at Singapore Clinical Supply Facility
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the completion…
Sernova’s Clinical Trial Supported With Continuous Glucose Monitoring Systems
Sernova Corp. recently announced continuous glucose monitoring systems [CGM (Medtronic Minimed, Northridge, CA)] will be provided to patients in Sernova’s US regenerative medicine clinical trial…
Amunix Announces Licensing Agreement With Celgene
Amunix Operating Inc. recently announced it has entered into a licensing agreement with Celgene. The agreement allows for the utilization of Amunix’s proprietary XTEN and…
Colorcon Makes Tablets Easier to Swallow
Dysphagia is a common ailment often experienced by the geriatric population. Opadry EZ, Easy Swallow Film Coating System, a new innovative product from Colorcon Inc,…
Soleno Therapeutics Announces Successful End-of-Phase II Meeting With FDA
Soleno Therapeutics, Inc. recently announced the successful completion of and receipt of minutes from its End-of-Phase 2 Meeting with the US FDA concerning Diazoxide Choline…
